BFC
IDXX icon

Bedel Financial Consulting’s Idexx Laboratories IDXX Stock Holding History

Bedel Financial Consulting’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8
Closed -$4K – 497
2022
Q1 		$4K Hold
8
– – ﹤0.01% 798
2021
Q4 		$5K Hold
8
– – ﹤0.01% 779
2021
Q3 		$5K Hold
8
– – ﹤0.01% 773
2021
Q2 		$5K Hold
8
– – ﹤0.01% 771
2021
Q1 		$4K Hold
8
– – ﹤0.01% 774
2020
Q4 		$4K Hold
8
– – ﹤0.01% 682
2020
Q3 		$3K Hold
8
– – ﹤0.01% 676
2020
Q2 		$3K Sell
8
-1
-11% -$290 ﹤0.01% 647
2020
Q1 		$2K Buy
9
+1
+13% +$261 ﹤0.01% 678
2019
Q4 		$2K Hold
8
– – ﹤0.01% 680
2019
Q3 		$2K Buy
+8
New +$2.23K ﹤0.01% 653

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Bedel Financial Consulting's IDXX Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 8 shares — an estimated $4K sold.

Bedel Financial Consulting first reported a position in IDXX in Q3 2019 and held it in 11 quarters. The position peaked at $5K in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 8 Idexx Laboratories shares in Q2 2022, an estimated $4K.
  • Bedel Financial Consulting first reported a position in Idexx Laboratories in Q3 2019 and held it in 11 quarters.
  • Bedel Financial Consulting's Idexx Laboratories position peaked at $5K in Q4 2021.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.